Team coverage of the heavy rain falling across the San Francisco Bay Area Tuesday with more intense precipitation ahead.

CNBC's TechCheck brings you the latest in tech news from CNBC's 1 Market in the heart of San Francisco. Some 10 people killed ...

Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, ...

Amazon and Google parent Alphabet are set to report earnings, along with other tech companies including AI darling Palantir, and chipmaker Advanced Micro Devices. Pharmaceutical firms Novo Nordisk, ...

Western drugmakers are striking more deals in China to access “bio-better” treatments for diseases from obesity to cancer, ...

Pfizer & Astellas’ Padcev plus Keytruda shows long-term efficacy in first-line treatment of locally advanced or metastatic urothelial cancer: New York Wednesday, February 12, 20 ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

Pharmaceutical firms Novo Nordisk, Eli Lilly, Merck, Amgen, and Pfizer are also ... Chicago Fed President Austan Goolsbee, and San Francisco Fed President Mary Daly. Earnings from Big Tech firms ...

Merck said on Tuesday it would not ship its ... Philips CEO sees subdued China sales this year Healthcare dealmakers gathering in San Francisco for the industry's premier annual conference this ...

Merck (NYSE:MRK) is preparing to launch a subcutaneously ... Davis on Monday at the JPMorgan Healthcare Conference in San Francisco. "That's actually new information and an acceleration from ...

To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Merck & Co.’s Keytruda is the world’s best-selling drug and has been a cancer juggernaut for more than a ...

The latest version of Keytruda could eventually capture between 30% and 40% of the market for the original, Merck CEO Rob Davis said at the JPMorgan Healthcare Conference in San Francisco on Monday.